Why the study?
Does psychosocial intervention improve outcomes, cost-effectiveness, and safety in cardiac patients?
Does psychosocial intervention improve outcomes, cost-effectiveness, and safety in cardiac patients?
This systematic review evaluates the clinical evidence regarding the efficacy, cost-effectiveness, and risks of psychosocial interventions for cardiac patients with comorbid mental health conditions.
Encourages routine mental health integration in cardiac care pathways; extends evidence synthesis on efficacy, costs, and risks for comorbid patients.
SUMMARY Cardiovascular disease (CVD) is the leading cause of death in the US. The growth of the older population in coming decades will inevitably increase the incidence of age-related cardiac disease. Increasing evidence has shown the prevalence of co-morbid mental health conditions in CVD patients. Specifically, depression and anxiety have been linked with CVD mortality. Due to the risk of psychosocial conditions with cardiac patients, mental health practitioners in health and gerontology need to be well-informed about CVD-related mental health co-morbidity and current research developments. Accordingly, this article provides a systematic review of the clinical evidence about the efficacy, cost-effectiveness, and any potential risk of psychosocial intervention with cardiac patients.
No takes yet. Share an insight, caveat, or question.
Peck et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: